FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162277955> ?p ?o ?g. }

• W2162277955 endingPage "1026" @default.
• W2162277955 startingPage "1016" @default.
• W2162277955 abstract "ABSTRACT Antimicrobials administered postexposure can reduce the incidence or progression of anthrax disease, but they do not protect against the disease resulting from the germination of spores that may remain in the body after cessation of the antimicrobial regimen. Such additional protection may be achieved by postexposure vaccination; however, no anthrax vaccine is licensed for postexposure prophylaxis (PEP). In a rabbit PEP study, animals were subjected to lethal challenge with aerosolized Bacillus anthracis spores and then were treated with levofloxacin with or without concomitant intramuscular (i.m.) vaccination with anthrax vaccine adsorbed (AVA) (BioThrax; Emergent BioDefense Operations Lansing LLC, Lansing, MI), administered twice, 1 week apart. A significant increase in survival rates was observed among vaccinated animals compared to those treated with antibiotic alone. In preexposure prophylaxis studies in rabbits and nonhuman primates (NHPs), animals received two i.m. vaccinations 1 month apart and were challenged with aerosolized anthrax spores at day 70. Prechallenge toxin-neutralizing antibody (TNA) titers correlated with animal survival postchallenge and provided the means for deriving an antibody titer associated with a specific probability of survival in animals. In a clinical immunogenicity study, 82% of the subjects met or exceeded the prechallenge TNA value that was associated with a 70% probability of survival in rabbits and 88% probability of survival in NHPs, which was estimated based on the results of animal preexposure prophylaxis studies. The animal data provide initial information on protective antibody levels for anthrax, as well as support previous findings regarding the ability of AVA to provide added protection to B. anthracis -infected animals compared to antimicrobial treatment alone." @default.
• W2162277955 created "2016-06-24" @default.
• W2162277955 creator A5002358114 @default.
• W2162277955 creator A5012134672 @default.
• W2162277955 creator A5019362951 @default.
• W2162277955 creator A5022063299 @default.
• W2162277955 creator A5026251789 @default.
• W2162277955 creator A5028122204 @default.
• W2162277955 creator A5029746428 @default.
• W2162277955 creator A5038700056 @default.
• W2162277955 creator A5039100400 @default.
• W2162277955 creator A5039298119 @default.
• W2162277955 creator A5039623410 @default.
• W2162277955 creator A5051174207 @default.
• W2162277955 creator A5053585805 @default.
• W2162277955 creator A5054805608 @default.
• W2162277955 creator A5069899684 @default.
• W2162277955 creator A5075671313 @default.
• W2162277955 creator A5084389949 @default.
• W2162277955 creator A5086332660 @default.
• W2162277955 date "2013-07-01" @default.
• W2162277955 modified "2023-09-27" @default.
• W2162277955 title "Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis" @default.
• W2162277955 cites W1553024508 @default.
• W2162277955 cites W1965688103 @default.
• W2162277955 cites W1983489319 @default.
• W2162277955 cites W1988669638 @default.
• W2162277955 cites W1993138958 @default.
• W2162277955 cites W2000171430 @default.
• W2162277955 cites W2018506593 @default.
• W2162277955 cites W2045941924 @default.
• W2162277955 cites W2050150132 @default.
• W2162277955 cites W2060463358 @default.
• W2162277955 cites W2087062858 @default.
• W2162277955 cites W2099691221 @default.
• W2162277955 cites W2112861955 @default.
• W2162277955 cites W2118599499 @default.
• W2162277955 cites W2130875615 @default.
• W2162277955 cites W2135062938 @default.
• W2162277955 cites W2142678238 @default.
• W2162277955 cites W2149033760 @default.
• W2162277955 cites W2150832852 @default.
• W2162277955 cites W2151313894 @default.
• W2162277955 cites W2156267465 @default.
• W2162277955 cites W2156740701 @default.
• W2162277955 cites W2172212022 @default.
• W2162277955 cites W4211172393 @default.
• W2162277955 doi "https://doi.org/10.1128/cvi.00099-13" @default.
• W2162277955 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3697458" @default.
• W2162277955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23658392" @default.
• W2162277955 hasPublicationYear "2013" @default.
• W2162277955 type Work @default.
• W2162277955 sameAs 2162277955 @default.
• W2162277955 citedByCount "52" @default.
• W2162277955 countsByYear W21622779552014 @default.
• W2162277955 countsByYear W21622779552015 @default.
• W2162277955 countsByYear W21622779552016 @default.
• W2162277955 countsByYear W21622779552017 @default.
• W2162277955 countsByYear W21622779552018 @default.
• W2162277955 countsByYear W21622779552019 @default.
• W2162277955 countsByYear W21622779552020 @default.
• W2162277955 countsByYear W21622779552021 @default.
• W2162277955 countsByYear W21622779552022 @default.
• W2162277955 countsByYear W21622779552023 @default.
• W2162277955 crossrefType "journal-article" @default.
• W2162277955 hasAuthorship W2162277955A5002358114 @default.
• W2162277955 hasAuthorship W2162277955A5012134672 @default.
• W2162277955 hasAuthorship W2162277955A5019362951 @default.
• W2162277955 hasAuthorship W2162277955A5022063299 @default.
• W2162277955 hasAuthorship W2162277955A5026251789 @default.
• W2162277955 hasAuthorship W2162277955A5028122204 @default.
• W2162277955 hasAuthorship W2162277955A5029746428 @default.
• W2162277955 hasAuthorship W2162277955A5038700056 @default.
• W2162277955 hasAuthorship W2162277955A5039100400 @default.
• W2162277955 hasAuthorship W2162277955A5039298119 @default.
• W2162277955 hasAuthorship W2162277955A5039623410 @default.
• W2162277955 hasAuthorship W2162277955A5051174207 @default.
• W2162277955 hasAuthorship W2162277955A5053585805 @default.
• W2162277955 hasAuthorship W2162277955A5054805608 @default.
• W2162277955 hasAuthorship W2162277955A5069899684 @default.
• W2162277955 hasAuthorship W2162277955A5075671313 @default.
• W2162277955 hasAuthorship W2162277955A5084389949 @default.
• W2162277955 hasAuthorship W2162277955A5086332660 @default.
• W2162277955 hasBestOaLocation W21622779551 @default.
• W2162277955 hasConcept C104317684 @default.
• W2162277955 hasConcept C105702510 @default.
• W2162277955 hasConcept C123894998 @default.
• W2162277955 hasConcept C159047783 @default.
• W2162277955 hasConcept C159654299 @default.
• W2162277955 hasConcept C167508917 @default.
• W2162277955 hasConcept C203014093 @default.
• W2162277955 hasConcept C22070199 @default.
• W2162277955 hasConcept C22889606 @default.
• W2162277955 hasConcept C2776954882 @default.
• W2162277955 hasConcept C2777289321 @default.
• W2162277955 hasConcept C2777351567 @default.
• W2162277955 hasConcept C2778283251 @default.
• W2162277955 hasConcept C2779841045 @default.

• next